Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-034207
Filing Date
2024-03-20
Accepted
2024-03-20 16:30:37
Documents
4
Effectiveness Date
2024-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 fusn-s8-2024.htm S-8 109365
2 EX-5.1 fusn-ex5_1.htm EX-5.1 9201
3 EX-23.1 fusn-ex23_1.htm EX-23.1 3079
4 EX-FILING FEES fusn-exfiling_fees.htm EX-FILING FEES 44230
  Complete submission text file 0000950170-24-034207.txt   166923
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278106 | Film No.: 24768182
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)